4//SEC Filing
McCubbin Quentin 4
Accession 0001127602-22-021369
CIK 0001703647other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:01 PM ET
Size
7.6 KB
Accession
0001127602-22-021369
Insider Transaction Report
Form 4
McCubbin Quentin
Chief Manufacturing Officer
Transactions
- Award
Stock Option
2022-08-17+90,000→ 90,000 totalExercise: $2.14Exp: 2031-01-28→ Common Stock (90,000 underlying) - Disposition to Issuer
Stock Option
2022-08-17−90,000→ 0 totalExercise: $38.99Exp: 2031-01-28→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable as to 25% on January 19, 2022, and in equal monthly installments on the same day of each month thereafter and will be fully vested and exercisable on January 19, 2025.
- [F2]The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001842009
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 4:01 PM ET
- Size
- 7.6 KB